Xvivo Perfusion AB

Xvivo Perfusion AB

200.60
SEK
+4.60
(+2.35%)
4.09EPS
53.83P/E
6.94BMarket Cap
Jan 28Next Earn

Xvivo Perfusion AB Documents

Q3 FY2025 · Interim report

October 23, 2025 · 28 pages

Read Xvivo Perfusion AB's results firsthand

Preview the first 2 pages of this interim report
Create a free account to start reading

Full documents are included with Professional

Q3 FY2025 documents